Abstract
Various abnormalities have been implicated in the transition of hypertrophy to heart failure but the exact mechanism is still unknown. Thus heart failure subsequent to hypertrophy remains a major clinical problem. Recently, oxidative stress has been suggested to play a critical role in the pathogenesis of heart failure. Here we describe antioxidant changes as well as their significance during hypertrophy and heart failure stages. Heart hypertrophy in rats and guinea pigs, in response to pressure over-load, is associated with an increase in ‘antioxidant reserve’ and a decrease in oxidative stress. Hypertrophied rat hearts show increased tolerance for different oxidative stress conditions such as those imposed by free radicals, hypoxia-reoxygenation and ischemia-reperfusion. On the other hand, heart failure under acute as well as chronic conditions is associated with reduced antioxidant reserve and increased oxidative stress. The latter may have a causal role as suggested by the protection seen with antioxidant treatment in acute as well as in chronic heart failure. It is becoming increasingly apparent that, anytime the available antioxidant reserve in the cell becomes inadequate, myocardial dysfunction is imminent.
This is a preview of subscription content, access via your institution.
References
Singal PK, Kirshenbaum LA: A relative deficit in antioxidant reserve may contribute in cardiac failure. Can J Cardiol 6: 47–49, 1990
Kaul N, Siveski-Iliskovic N, Hill M, Slezák J, Singal PK: Free radicals and the heart. J Pharmacol Toxicol Meth 30: 55–67, 1993
Curello S, Ceconi C, Bigoli C, Ferrari R, Albertini A, Guarnien C: Change in the cardiac glutathione after ischemia and reperfusion. Experimentia 41: 42–43, 1985
Ferrari R, Ceconi C, Curello S, Guarnieri C, Caldarera CM, Albertini A, Visioli O: Oxygen-mediated myocardial damage during ischemia and reperfusion: role of the cellular defenses against oxygen toxicity. J Mol Cell Cardiol 17: 937–945, 1985
Guarnieri C, Flamigni F, Caldarera CM: Role of oxygen in cellular damage induced by reoxygenation of hypoxic heart. J Mol Cell Cardiol 12: 797–808, 1980
Dhaliwal H, Kirschenbaum LA, Randhawa AK, Singal PK: Correlation between antioxidant changes during hypoxia and recovery upon reoxygenation. Am J Physiol 261: H632-H638, 1991
Dhalla AK, Singal PK: Antioxidant changes in hypertrophied and failing guinea pig hearts. Am J Physiol 266 (Heart Circ Physiol): H1280-H1285, 1994
Singal PK, Dhalla AK, Hill M, Thomas TP: Endogenous antioxidant changes in the myocardium in response to acute and chronic stress conditions. Mol Cell Biochem 129: 179–186, 1993
Gupta M, Singal PK: Higher antioxidative capacity during a chronic stable heart hypertrophy. Circ Res 64: 398–406, 1989
Higuchi M, Cartier LJ, Chen M, Holloszy JO: Superoxide dismutase and catalase in skeletal muscle: adaptive response to exercise. J Gerontology 40: 281–286, 1985
Kanter MM, Hamlin RL, Unverferth DV, Davis HW, Merola AJ: Effect of exercise training on antioxidant enzymes and cardiotoxicity of doxorubicin. J Appl Physiol 59: 1298–1303, 1985
Kirshenbaum LA, Singal PK: Antioxidant changes in heart hypertrophy: significance during hypoxia-reoxygenation injury. Can J Physiol Pharmacol 70: 1330–1335, 1992
Kirshenbaum LA, Singal PK: Increase in endogenous antioxidant enzymes protects the heart against reperfusion injury. Am J Physiol 265: H484-H493, 1993
Kirshenbaum LA, Hill M, Singal PK: Endogenous antioxidants in isolated hypertrophied cardiac myocytes and hypoxia-reoxygenation injury. J Mol Cell Cardiol 27: 263–272, 1995
Randhawa, AK, Singal PK: Pressure overload-induced cardiac hypertrophy with and without dilation. J Am Coll Cardiol 20: 1569–1575, 1992
Singal PK, Deally CMR, Weinberg LE: Subcellular effects of adriamycin in the heart: a concise review. J Mol Cell Cardiol 19: 817–828, 1987
Siveski-Iliskovic N, Kaul N, Singal PK Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats. Circulation 89: 2829–2835, 1994
Kirshenbaum LA, Singal PK: Changes in antioxidant enzymes in isolated cardiac myocytes subjected to hypoxia-reoxygenation. Lab Invest 67 (6): 796–803, 1992
Ferrari R, Curello S, Ceconi C, Cargnoni A, Condorelli E, Albertini A: Alterations of glutathione status during myocardial ischemia and reperfusion. In: P.K. Singal (ed). Oxygen Radicals in the Pathophysiology of Heart Disease. Kluwer Academic Press, Massachussets, 1988 pp 145–160
Siveski-Iliskovic N, Hill M, Chow DA, Singal PK: Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect. Circulation 1995 (in press)
Guarnieri C, Muscari C, Caldarera CM, Slefanelli C, Pretolani E: The effect of treatment with coenzyme Q10 on the mitochondrial function and superoxide radical formation in cardiac muscle hypertrophied by mild stenosis. J Mol Cell Cardiol 19: 63–71, 1985
Kobayashi A, Yamashita T, Kaneko M, Nishiyama T, Hayashi H, Yamaszaki N: Effect of verapamil on experimental cardiomyopathy in the bio 14.6 Syrian hamster. J Am Coll Cardiol 10: 1128–1134, 1987
Werns SW, Lucchesi BR: The role of the polymorphonuclear leukocyte in mediating myocardial reperfusion injury. In: P.K. Singal (ed). Oxygen Radicals in the Pathophysiology of Heart Disease. Kluwer Academic Press, Massachussets, 1988, pp 123–144
Janero DR: Therapeutic potential of vitamin E against myocardial ischemia-reperfusion injury. Free Rad Biol Med 10: 315–324, 1991
van Acker SABE, Koymans LMH, Bast A: Molecular pharmacology of vitamin E: structural aspects of antioxidant activity. Free Rad Biol Med 15: 311–328, 1993
Dhalla AK, Singal PK: Vitamin E delays pathogenesis of heart failure due to chronic pressure overload. Can J Cardiology 10(A): 72A, 1994
Dhalla AK, Singh N, Singal PK: Antioxidant therapy associated with the reversal of oxidative stress, delays the pathogenesis of heart failure. Circulation 1995 (in press)
Packer L: Vitamin E is nature's master antioxidant. Scientific American Science and Medicine 1: 54–63, 1994
Massey KD, Burton KP: Alpha-tocopherol attenuates myocardial membrane-related alterations resulting from ischemia and reperfusion. Am J Physiol 256: H1192-H1199, 1989
Ferrari R, Visiolo O, Guarnieri C, Caldarera M: Vitamin E and the heart: possible role as antioxidant. Acta Vitaminol Enzymol 5: 11–22, 1983
Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC: Vitamin E consumption and the risk of coronary disease in men. N Eng J Med 328: 1450–1456, 1993
Stampfer MJ, Hennekens CN, Manson JE, Colditz GA, Rosner B, Willett WC: Vitamin E consumption and the risk of coronary disease in women. N Eng J Med 328: 1444–1449, 1993
Mickle DAG, Li RK, Weisel RD, Birnbaum PL, Wu TW, Jackawski G, Madonik MM, Burton GW, Ingold KU: Myocardial salvage with Trolox and ascorbic acid for an acute evolving infarction. Ann Thorac Surg 47: 553–557, 1989
Rosenfeld W, Evans H, Jhaveri R, Moainie H, Vohra K, Georgatos E, Salazar JD: Safety and plasma concentrations of bovine superoxide dismutase administered to human premature infants. Dev Pharmacol Ther 5: 151–161, 1982
Iarema NI, Konovalova GG, Lankin VZ: Changes in the activity of antioxidant enzymes in patients with hypertension. Kardiologia 32(3): 46–48, 1992
Ceriello A, Giugliano D, Quatraro A, Lefebvre PJ: Antioxidants show an antihypertensive effect in diabetic and hypertensive subjects. Clin Sci Colch 81(6): 739–742, 1991
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Singh, N., Dhalla, A.K., Seneviratne, C. et al. Oxidative stress and heart failure. Mol Cell Biochem 147, 77–81 (1995). https://doi.org/10.1007/BF00944786
Issue Date:
DOI: https://doi.org/10.1007/BF00944786
Key words
- antioxidants
- redox state
- lipid peroxidation